Literature DB >> 28968141

Aberrant alterations of the expressions and S-nitrosylation of calmodulin and the downstream factors in the brains of the rodents during scrapie infection.

Ren-Qing Zhang1,2, Cao Chen2, Li-Jie Xiao1, Jing Sun2, Yue Ma2, Xiao-Dong Yang2, Xiao-Feng Xu2, Kang Xiao2, Qi Shi2, Zhi-Bao Chen1, Xiao-Ping Dong2.   

Abstract

The aberrant alterations of calmodulin (CaM) and its downstream substrates have been reported in some neurodegenerative diseases, but rarely described in prion disease. In this study, the potential changes of Ca2+/CaM and its associated agents in the brains of scrapie agent 263K-infected hamsters and the prion infected cell line SMB-S15 were evaluated by various methodologies. We found that the level of CaM in the brains of 263K-infected hamsters started to increase at early stage and maintained at high level till terminal stage. The increased CaM mainly accumulated in the regions of cortex, thalamus and cerebellum of 263K-infected hamsters and well localization of CaM with NeuN positive cells. However, the related kinases such as total and phosphorylated forms of CaMKII and CaMKIV, as well as the downstream proteins such as CREB and BDNF in the brain of 263K-infected hamsters were decreased. Further analysis showed a remarkable increase of S-nitrosylated (SNO) form of CaM in the brains of 263K-infected hamsters. Dynamic analysis of S-nitrosylated CaM showed the SNO form of CaM abnormally increases in a time-dependent manner during prion infection. Compared with that of the normal partner cell line SMB-PS, the CaM level in SMB-S15 cells was increased, meanwhile, the downstream proteins, such as CaMKII, p-CaMKII, CREB, as well as BDNF, were also increased, especially in the nucleic fraction. No SNO-CaM was detected in the cell lines SMB-S15 and SMB-PS. Our data indicate an aberrant increase of CaM during prion infection in vivo and in vitro.

Entities:  

Keywords:  CaMKII; CaMKIV; S-nitrosylation; calmodulin; prion infection

Mesh:

Substances:

Year:  2017        PMID: 28968141      PMCID: PMC5639865          DOI: 10.1080/19336896.2017.1367082

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  38 in total

Review 1.  Apocalmodulin.

Authors:  L A Jurado; P S Chockalingam; H W Jarrett
Journal:  Physiol Rev       Date:  1999-07       Impact factor: 37.312

Review 2.  Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease.

Authors:  Frank M LaFerla
Journal:  Nat Rev Neurosci       Date:  2002-11       Impact factor: 34.870

3.  Calmodulin and cell proliferation.

Authors:  Y Sasaki; H Hidaka
Journal:  Biochem Biophys Res Commun       Date:  1982-01-29       Impact factor: 3.575

Review 4.  Protein S-nitrosylation: purview and parameters.

Authors:  Douglas T Hess; Akio Matsumoto; Sung-Oog Kim; Harvey E Marshall; Jonathan S Stamler
Journal:  Nat Rev Mol Cell Biol       Date:  2005-02       Impact factor: 94.444

Review 5.  Calmodulin in action: diversity in target recognition and activation mechanisms.

Authors:  Klaus P Hoeflich; Mitsuhiko Ikura
Journal:  Cell       Date:  2002-03-22       Impact factor: 41.582

Review 6.  Aberrant protein s-nitrosylation in neurodegenerative diseases.

Authors:  Tomohiro Nakamura; Shichun Tu; Mohd Waseem Akhtar; Carmen R Sunico; Shu-Ichi Okamoto; Stuart A Lipton
Journal:  Neuron       Date:  2013-05-22       Impact factor: 17.173

7.  Downregulation of extracellular signal-regulated kinase 1/2 activity by calmodulin KII modulates p21Cip1 levels and survival of immortalized lymphocytes from Alzheimer's disease patients.

Authors:  Noemí Esteras; Carolina Alquézar; Félix Bermejo-Pareja; Emilia Bialopiotrowicz; Urszula Wojda; Angeles Martín-Requero
Journal:  Neurobiol Aging       Date:  2012-11-13       Impact factor: 4.673

8.  Different expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathies.

Authors:  Jian-Ming Chen; Chen Gao; Qi Shi; Bing Shan; Yan-Jun Lei; Chen-Fang Dong; Run An; Gui-Rong Wang; Bao-Yun Zhang; Jun Han; Xiao-Ping Dong
Journal:  Arch Virol       Date:  2008-04-11       Impact factor: 2.574

Review 9.  An overview of human prion diseases.

Authors:  Muhammad Imran; Saqib Mahmood
Journal:  Virol J       Date:  2011-12-24       Impact factor: 4.099

10.  Calmodulin levels in blood cells as a potential biomarker of Alzheimer's disease.

Authors:  Noemí Esteras; Carolina Alquézar; Ana de la Encarnación; Alberto Villarejo; Félix Bermejo-Pareja; Angeles Martín-Requero
Journal:  Alzheimers Res Ther       Date:  2013-11-07       Impact factor: 6.982

View more
  2 in total

1.  Decrease of RyR2 in the prion infected cell line and in the brains of the scrapie infected mice models and the patients of human prion diseases.

Authors:  Qi Shi; Jian-Le Li; Yue Ma; Li-Ping Gao; Kang Xiao; Jing Wang; Wei Zhou; Cao Chen; Yan-Jun Guo; Xiao-Ping Dong
Journal:  Prion       Date:  2018-06-07       Impact factor: 3.931

2.  Significant enhanced expressions of aquaporin-1, -4 and -9 in the brains of various prion diseases.

Authors:  Qi Shi; Yue-Zhang Wu; Xuehua Yang; Kang Xiao; Adalaiti Maimaitiming; Li-Ping Gao; Cao Chen; Chen Gao; Yanjun Guo; Xiao-Ping Dong
Journal:  Prion       Date:  2019-01       Impact factor: 3.931

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.